(Q42929748)

English

In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis

scientific article published on February 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis (English)

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

cystic fibrosis

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

Pseudomonas cepacia

object named as

P. cepacia

1 reference

based on heuristic

inferred from title

author name string

Aronoff SC

1

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Klinger JD

2

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

language of work or name

0 references

publication date

1 February 1984

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

25

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

2

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

279-280

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185490

27 May 2018

In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185490

27 May 2018

Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185490

27 May 2018

In-vitro antibacterial activity of SQ 26,776.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185490

16 August 2018

Correlations between methods for measurement of synergy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6561954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind controlled trial of anti-Pseudomonas chemotherapy of acute respiratory exacerbations in patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/6561954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp

1 reference

https://pubmed.ncbi.nlm.nih.gov/6561954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.25.2.279

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42929748&oldid=1974006058"